BioCentury | May 18, 2015
Company News

San Raffaele, MolMed deal

...companies could not be reached for details. MolMed, which was formed as a JV between Boehringer Mannheim...
...treat cancer and AIDS (see BioCentury, Nov. 25, 1996). Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland) acquired Boehringer Mannheim...
BioCentury | Oct 9, 2014
Company News

Deal-maker Max Link passes away

...and a $220 million deal with cell separation specialist CellPro Inc. Corange, the parent of Boehringer Mannheim...
BioCentury | Apr 15, 2013
Company News

Igen, Boehringer Mannheim GmbH deal

...IGEN received a $6 million advance payment on 1997 royalties from partner Boehringer Mannheim. The payments arise...
...advance will be creditable against royalties in subsequent years. Igen International Inc. (IGEN), Gaithersburg, Md. Boehringer Mannheim...
BioCentury | Apr 15, 2013
Clinical News

Protovir human antibody targeted to cytomegalovirus data

...of the agent in Europe and the rest of the world have been licensed to Boehringer Mannheim...
BioCentury | Apr 15, 2013
Company News

Technical Chemicals, Boehringer Mannheim Argentina SACIeI deal

...drugs of abuse and cancer screening. Technical Chemicals & Products Inc. (TCPI), Pompano Beach, Fla. Boehringer Mannheim...
BioCentury | Feb 7, 2011
Finance

Savient reloads to go it alone

...in 1997 by Stefan Engelhorn, a member of one of the families that formerly owned Boehringer Mannheim...
BioCentury | Feb 7, 2011
Finance

BioNet's Scil Set

...in 1997 by Stefan Engelhorn, a member of one of the families that formerly owned Boehringer Mannheim...
BioCentury | Mar 27, 2006
Product Development

Removing toxicity

...failed. The core of EPD is a set of specific carrier molecules, originally discovered at Boehringer Mannheim...
BioCentury | Oct 17, 2005
Company News

febit biotech GmbH board of directors update

...biotech GmbH , Heidelberg, Germany Business: Microarrays Appointed: Gerald Moller, former president and CEO at Boehringer Mannheim...
BioCentury | Jul 28, 2003
Company News

Igen, Roche deal

...$18.6 million in cash for compensatory damages related to litigation concerning Origen between IGEN and Boehringer Mannheim...
Items per page:
1 - 10 of 202
BioCentury | May 18, 2015
Company News

San Raffaele, MolMed deal

...companies could not be reached for details. MolMed, which was formed as a JV between Boehringer Mannheim...
...treat cancer and AIDS (see BioCentury, Nov. 25, 1996). Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland) acquired Boehringer Mannheim...
BioCentury | Oct 9, 2014
Company News

Deal-maker Max Link passes away

...and a $220 million deal with cell separation specialist CellPro Inc. Corange, the parent of Boehringer Mannheim...
BioCentury | Apr 15, 2013
Company News

Igen, Boehringer Mannheim GmbH deal

...IGEN received a $6 million advance payment on 1997 royalties from partner Boehringer Mannheim. The payments arise...
...advance will be creditable against royalties in subsequent years. Igen International Inc. (IGEN), Gaithersburg, Md. Boehringer Mannheim...
BioCentury | Apr 15, 2013
Clinical News

Protovir human antibody targeted to cytomegalovirus data

...of the agent in Europe and the rest of the world have been licensed to Boehringer Mannheim...
BioCentury | Apr 15, 2013
Company News

Technical Chemicals, Boehringer Mannheim Argentina SACIeI deal

...drugs of abuse and cancer screening. Technical Chemicals & Products Inc. (TCPI), Pompano Beach, Fla. Boehringer Mannheim...
BioCentury | Feb 7, 2011
Finance

Savient reloads to go it alone

...in 1997 by Stefan Engelhorn, a member of one of the families that formerly owned Boehringer Mannheim...
BioCentury | Feb 7, 2011
Finance

BioNet's Scil Set

...in 1997 by Stefan Engelhorn, a member of one of the families that formerly owned Boehringer Mannheim...
BioCentury | Mar 27, 2006
Product Development

Removing toxicity

...failed. The core of EPD is a set of specific carrier molecules, originally discovered at Boehringer Mannheim...
BioCentury | Oct 17, 2005
Company News

febit biotech GmbH board of directors update

...biotech GmbH , Heidelberg, Germany Business: Microarrays Appointed: Gerald Moller, former president and CEO at Boehringer Mannheim...
BioCentury | Jul 28, 2003
Company News

Igen, Roche deal

...$18.6 million in cash for compensatory damages related to litigation concerning Origen between IGEN and Boehringer Mannheim...
Items per page:
1 - 10 of 202